Cryoport, Inc.
Financials
Valuation Metrics
Cryoport, Inc.'s Market Cap is $846M. At end of 2025 it was $478M. Ranked #2557 of 3,121 in US market (top 82%), #1071 of 1,463 on NASDAQ (top 73%), #84 of 93 in Transportation (top 90%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $846M | US#2,557/3,121 Sec#84/93 |
| Revenue | $186M | US#2,590/3,121 Sec#88/93 |
| Net Income | $-36M | US—/3,121 Sec—/93 |
| Total Assets | $756M | US#2,599/3,121 Sec#91/93 |
| Net Assets | $491M | US#2,245/3,121 Sec#79/93 |
| Employees | 688 | US#2,143/3,121 Sec#75/93 |
| Value | ||
| P/B | 1.72x | US#1,055/3,121 Sec#31/93 |
| P/S | 4.54x | US#2,215/3,121 Sec#79/93 |
| FCF Yield | -2.40% | US—/3,121 Sec—/93 |
| Profitability | ||
| ROE | -7.39% | US#2,318/3,121 Sec#80/93 |
| ROA | -4.80% | US#2,509/3,121 Sec#86/93 |
| Op. Margin | -21.25% | US#2,610/3,121 Sec#88/93 |
| Financial Health | ||
| Debt Ratio | 54.11% | US#622/3,121 Sec#13/93 |
| Total Debt | $232M | US#2,209/3,121 Sec#83/93 |
| FCF | $-20M | US#2,427/3,121 Sec#66/93 |
| Cash | $269M | US#1,500/3,121 Sec#48/93 |
| Current Ratio | 2.08x | US#1,193/3,121 Sec#22/93 |
| Performance | ||
| 1Y Return | 89.18% | US#261/3,121 Sec#10/93 |
| 1M Return | 11.20% | US#212/3,121 Sec#10/93 |
| From 52W High | -2.44% | US#130/3,121 Sec#12/93 |
| 1Y MDD | -31.50% | US#1,528/3,121 Sec#62/93 |
| Trading | ||
| Volume | 598,787 shares | US#1,853/3,121 Sec#49/93 |
| Trading Value | $10M | US#2,344/3,121 Sec#74/93 |
| Per Share | ||
| EPS | $-0.72 | US—/3,121 Sec—/93 |
| BPS | $9.74 | US#1,866/3,121 Sec#65/93 |
Company Info
Cryoport, Inc. operates as a specialized service provider within the life sciences sector, delivering global temperature-controlled supply chain solutions across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Central to their offerings is Cryoportal, a proprietary cloud-based platform designed to streamline the entire logistics process. This robust system facilitates order processing, generates necessary documentation (including customs paperwork), coordinates courier services, offers real-time shipment tracking and monitoring, aids in issue resolution, and ensures adherence to regulatory compliance standards. To guarantee the integrity of sensitive materials during transit, Cryoport provides CryoPort Express Shippers, engineered to maintain the stability of biological commodities throughout their journey. Furthermore, their SmartPak Condition Monitoring System collects vital environmental data, which is then utilized to produce informative dashboards and essential validation reports for each shipment. Their product range also includes specialized containment solutions such as vacuum insulated aluminum dewars and advanced cryogenic freezer systems. Beyond transportation, the company offers extensive biological specimen management services. These encompass cryopreservation storage and ongoing maintenance, meticulous archiving, continuous monitoring, precise tracking, and efficient receipt and delivery of samples. They also manage the transport of frozen biological specimens to and from client facilities and oversee the inbound and outbound flow of these critical materials. Additionally, Cryoport extends its expertise through comprehensive logistics support and management services, alongside short-term consulting in both logistics and engineering. The company primarily caters to the biopharmaceutical, animal health, and human reproductive medicine industries. Founded in 1999, Cryoport's headquarters are situated in Brentwood, Tennessee.